Nerbacadol is significantly positively correlated with high expression of HOXB-AS4 and drug resistance in head and neck squamous cell carcinoma. Nerbacadol can be used in relevant research on head and neck squamous cell carcinoma[1].
Molecular Weight:
194.23
Purity:
95
CAS Number:
[99803-72-2]
Formula:
C10H14N2O2
Target:
Biochemical Assay Reagents
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted